Literature DB >> 28683215

Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites.

Michael K Gould1, Lori C Sakoda2, Debra P Ritzwoller3, Michael J Simoff4, Christine M Neslund-Dudas5, Lawrence H Kushi2, Lisa Carter-Harris6, Heather Spencer Feigelson3, George Minowada7, V Paul Doria-Rose8.   

Abstract

RATIONALE: Lung cancer screening registries can monitor screening outcomes and improve quality of care.
OBJECTIVES: To describe nascent lung cancer screening programs and share efficient data collection approaches for mandatory registry reporting in four integrated health care systems of the National Cancer Institute-funded Cancer Research Network.
METHODS: We documented the distinctive characteristics of lung cancer screening programs, and we provide examples of strategies to facilitate data collection and describe early challenges and possible solutions. In addition, we report preliminary data on use and outcomes of screening with low-dose computed tomography at each of the participating sites.
RESULTS: Programs varied in approaches to confirming patient eligibility, ordering screening low-dose computed tomographic scans, and coordinating follow-up care. Most data elements were collected from structured fields in electronic health records, but sites also made use of standardized order templates, local procedure codes, identifiable hashtags in radiology reports, and natural language processing algorithms. Common challenges included incomplete documentation of tobacco smoking history, difficulty distinguishing between scans performed for screening versus diagnosis or surveillance, and variable adherence with use of standardized templates. Adherence with eligibility criteria as well as the accuracy and completeness of data collection appeared to depend at least partly on availability of personnel and other resources to support the successful implementation of screening.
CONCLUSIONS: To maximize the effectiveness of lung cancer screening, minimize the burden of data collection, and facilitate research and quality improvement, clinical workflow and information technology should be purposefully designed to ensure that patients meet eligibility criteria and receive appropriate follow-up testing.

Entities:  

Keywords:  electronic health records; lung cancer; registry; screening

Mesh:

Year:  2017        PMID: 28683215      PMCID: PMC5711261          DOI: 10.1513/AnnalsATS.201703-237OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  22 in total

Review 1.  Setting up a lung cancer screening program.

Authors:  Douglas Arenberg; Ella A Kazerooni
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

2.  The rationale for, and design of, a lung cancer screening program.

Authors:  Peter Mazzone
Journal:  Cleve Clin J Med       Date:  2012-05       Impact factor: 2.321

3.  Better evidence about screening for lung cancer.

Authors:  Harold C Sox
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

4.  National lung screening trial: variability in nodule detection rates in chest CT studies.

Authors:  Paul F Pinsky; David S Gierada; P Hrudaya Nath; Ella Kazerooni; Judith Amorosa
Journal:  Radiology       Date:  2013-04-16       Impact factor: 11.105

5.  Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing.

Authors:  Kim N Danforth; Megan I Early; Sharon Ngan; Anne E Kosco; Chengyi Zheng; Michael K Gould
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

6.  Building a virtual cancer research organization.

Authors:  Mark C Hornbrook; Gene Hart; Jennifer L Ellis; Donald J Bachman; Gary Ansell; Sarah M Greene; Edward H Wagner; Roy Pardee; Mark M Schmidt; Ann Geiger; Amy L Butani; Terry Field; Hassan Fouayzi; Irina Miroshnik; Liyan Liu; Robert Diseker; Karen Wells; Rick Krajenta; Lois Lamerato; Christine Neslund Dudas
Journal:  J Natl Cancer Inst Monogr       Date:  2005

Review 7.  Building a research consortium of large health systems: the Cancer Research Network.

Authors:  Edward H Wagner; Sarah M Greene; Gene Hart; Terry S Field; Suzanne Fletcher; Ann M Geiger; Lisa J Herrinton; Mark C Hornbrook; Christine C Johnson; Judy Mouchawar; Sharon J Rolnick; Victor J Stevens; Stephen H Taplin; Dennis Tolsma; Thomas M Vogt
Journal:  J Natl Cancer Inst Monogr       Date:  2005

8.  Initial experience with a free, high-volume, low-dose CT lung cancer screening program.

Authors:  Brady J McKee; Andrea B McKee; Sebastian Flacke; Carla R Lamb; Paul J Hesketh; Christoph Wald
Journal:  J Am Coll Radiol       Date:  2013-04-26       Impact factor: 5.532

9.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

10.  Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.

Authors:  V Paul Doria-Rose; Mary C White; Carrie N Klabunde; Marion R Nadel; Thomas B Richards; Timothy S McNeel; Juan L Rodriguez; Pamela M Marcus
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-09       Impact factor: 4.254

View more
  18 in total

1.  Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.

Authors:  Chyke A Doubeni; Debra P Ritzwoller; Katharine A Rendle; Andrea N Burnett-Hartman; Christine Neslund-Dudas; Robert T Greenlee; Stacey Honda; Jennifer Elston Lafata; Pamela M Marcus; Mary E Cooley; Anil Vachani; Rafael Meza; Caryn Oshiro; Michael J Simoff; Mitchell D Schnall; Elisabeth F Beaber; V Paul Doria-Rose
Journal:  Cancer Prev Res (Phila)       Date:  2019-12-23

2.  Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.

Authors:  Ashish Rai; V Paul Doria-Rose; Gerard A Silvestri; K Robin Yabroff
Journal:  J Natl Cancer Inst       Date:  2019-04-01       Impact factor: 13.506

3.  Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Authors:  William E Barlow; Elisabeth F Beaber; Berta M Geller; Aruna Kamineni; Yingye Zheng; Jennifer S Haas; Chun R Chao; Carolyn M Rutter; Ann G Zauber; Brian L Sprague; Ethan A Halm; Donald L Weaver; Jessica Chubak; V Paul Doria-Rose; Sarah Kobrin; Tracy Onega; Virginia P Quinn; Marilyn M Schapira; Anna N A Tosteson; Douglas A Corley; Celette Sugg Skinner; Mitchell D Schnall; Katrina Armstrong; Cosette M Wheeler; Michael J Silverberg; Bijal A Balasubramanian; Chyke A Doubeni; Dale McLerran; Jasmin A Tiro
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

4.  Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.

Authors:  Shawn P E Nishi; Jie Zhou; Ikenna Okereke; Yong-Fang Kuo; James Goodwin
Journal:  Chest       Date:  2019-09-12       Impact factor: 9.410

5.  Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.

Authors:  Thomas B Richards; V Paul Doria-Rose; Ashwini Soman; Carrie N Klabunde; Ralph S Caraballo; Simone C Gray; Keisha A Houston; Mary C White
Journal:  Am J Prev Med       Date:  2018-11-19       Impact factor: 5.043

6.  Effectiveness of a Patient Education Class to Enhance Knowledge about Lung Cancer Screening: a Quality Improvement Evaluation.

Authors:  Lori C Sakoda; Melanie A Meyer; Neetu Chawla; Michael A Sanchez; Maruta A Blatchins; Sundeep Nayak; Karen San; Gary K Zin; George Minowada
Journal:  J Cancer Educ       Date:  2020-10       Impact factor: 2.037

7.  Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.

Authors:  Andrea N Burnett-Hartman; Nikki M Carroll; Stacey A Honda; Caroline Joyce; Nandita Mitra; Christine Neslund-Dudas; Oluwatosin Olaiya; Katharine A Rendle; Mitchell D Schnall; Anil Vachani; Debra P Ritzwoller
Journal:  Ann Am Thorac Soc       Date:  2022-03

8.  Preempting Racial Inequities in Lung Cancer Screening.

Authors:  Jennifer Richmond; Olive M Mbah; Sofia Z Dard; Lauren C Jordan; Katherine S Cools; Cleo A Samuel; Jalaal M Khan; Matthew A Manning
Journal:  Am J Prev Med       Date:  2018-10-19       Impact factor: 5.043

9.  Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.

Authors:  Nikki M Carroll; Andrea N Burnett-Hartman; Caroline A Joyce; William Kinnard; Eric J Harker; Virginia Hall; Julie S Steiner; Erica Blum-Barnett; Debra P Ritzwoller
Journal:  J Gen Intern Med       Date:  2020-01-23       Impact factor: 5.128

10.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.